1. In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide
   Tingyu Li et al, 2022, Journal of Cancer Research and Clinical Oncology CrossRef
2. Preclinical pharmacology and toxicology study of Ad-hTERT-E1a-Apoptin, a novel dual cancer-specific oncolytic adenovirus
   Yanxin Qi et al, 2014, Toxicology and Applied Pharmacology CrossRef
3. Synergistic antitumor effect of the combination of a dual cancer‑specific oncolytic adenovirus and cisplatin on lung cancer cells
   Jing Jin et al, 2018, Oncology Letters CrossRef
4. Apoptin mediates mitophagy and endogenous apoptosis by regulating the level of ROS in hepatocellular carcinoma
   Yiquan Li et al, 2022, Cell Communication and Signaling CrossRef
5. Ad-VT causes ovarian cancer A2780 cell death via mitochondrial apoptosis and autophagy pathways
   Yingli Cui et al, 2024, Translational Oncology CrossRef
6. Viral genes as oncolytic agents for cancer therapy
   Shishir Kumar Gupta et al, 2015, Cellular and Molecular Life Sciences CrossRef
7. Apoptins: selective anticancer agents
   Oscar M. Rollano Peñaloza et al, 2014, Trends in Molecular Medicine CrossRef
8. Antitumor effect of a dual cancer-specific oncolytic adenovirus on prostate cancer PC-3 cells
   Chuan-xin Cui et al, 2019, Urologic Oncology: Seminars and Original Investigations CrossRef
9. Ad-Apoptin-hTERTp-E1a Regulates Autophagy Through the AMPK-mTOR-eIF4F Signaling Axis to Reduce Drug Resistance of MCF-7/ADR Cells
   Yaru Li et al, 2021, Frontiers in Molecular Biosciences CrossRef
10. Antitumor effect of the Newcastle disease viral hemagglutinin–neuraminidase gene is expressed through an oncolytic adenovirus effect in osteosarcoma cells
    Shuang Chen et al, 2018, Anti-Cancer Drugs CrossRef
11. Anti-tumor Synergistic Effect of a Dual Cancer-Specific Recombinant Adenovirus and Paclitaxel on Breast Cancer
    Jing Wang et al, 2020, Frontiers in Oncology CrossRef
12. Anti‐tumour effects of a dual cancer‐specific oncolytic adenovirus on Breast Cancer Stem cells
    Wenjie Li et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
13. Suppression effect of a dual cancer-specific oncolytic adenovirus on luciferase-labeled human melanoma cells in vitro and in vivo
    Min Li et al, 2021, Cancer Biomarkers CrossRef
14. Antitumor effects of a dual cancer-specific oncolytic adenovirus on colorectal cancer in vitro and in vivo
    GUOHUA YANG et al, 2015, Experimental and Therapeutic Medicine CrossRef
15. Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine
    Xing Liu et al, 2020, Frontiers in Oncology CrossRef
16. Targeting strategies of adenovirus-mediated gene therapy and virotherapy for prostate cancer
    Zhonglin Cai et al, 2017, Molecular Medicine Reports CrossRef
17. Anti-tumor effect of a dual cancer-specific recombinant adenovirus on ovarian cancer cells
    Yingli Cui et al, 2020, Experimental Cell Research CrossRef
18. Apoptin Towards Safe and Efficient Anticancer Therapies
    Claude Backendorf et al, 2014, Anticancer Genes CrossRef
19. Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo
    Jing Wang et al, 2022, Cancer Management and Research CrossRef
20. Tissue Specific Promoters in Colorectal Cancer
    A. R. Rama et al, 2015, Disease Markers CrossRef
21. A dual cancer-specific recombinant adenovirus suppresses the growth of liver cancer cells in vivo and in vitro
    Yufei Tian et al, 2020, Anti-Cancer Drugs CrossRef
22. The Role of Apoptin in Chicken Anemia Virus Replication
    Cynthia Feng et al, 2020, Pathogens CrossRef
23. Ad-VT enhances the sensitivity of chemotherapy-resistant lung adenocarcinoma cells to gemcitabine and paclitaxel in vitro and in vivo
    Gaojie Song et al, 2022, Investigational New Drugs CrossRef